Available Technology

Combination of glivec (STI571) with a cyclin-dependent kinase inhibitor, especially flavopiridol, in the treatment of cancer

Patent Number: 
7,888,341
Internal Laboratory Ref #: 
02-072
Share to Facebook Share to Twitter Share to Google Plus Share to Linkedin